BSX
BOSTON SCIENTIFIC CORP
NYSE: BSX · Marlborough, MA · Healthcare
$44.25+0.67 (+1.54%)Closed
Market Cap$61.92B
Cash$1.45Bmost recent
Runwayprofitable
P/E (TTM)22.8EPS $1.94
52-Wk Range$42.63 – $108.14
Avg Volume13.9M3-month
Price & Trading Activity

Daily close with catalyst overlays and trading volume

$44.25-40.4%
Pipeline

Drug candidates sponsored by BOSTON SCIENTIFIC · ClinicalTrials.gov

99 drugs · 100 trials
PhaseDrug / CandidateIndicationsStatusNext CompletionTrials
Phase 4Unnamed
Cardiovascular Disease+1 more
Completed
2006-11past
1
Phase 4Unnamed
Coronary Artery Disease
Completed
2007-04past
1
Phase 4Unnamed
Carotid Stenosis
Terminated
2009-07past
1
Phase 4Unnamed
Myocardial Infarction
Completed
2009-10past
1
Phase 4Unnamed
Leiomyoma+4 more
Completed
2009-12past
1
Phase 4Alteplase
Deep Vein Thrombosis+1 more
Completed
2017-11-30past
1
Phase 4Chemotherapy
Metastatic Liver Cancer+2 more
Withdrawn—1
Phase 3Unnamed
Transient Ischemic Attack+2 more
Completed
2005-03past
1
Phase 3Unnamed
Coronary Artery Disease
Completed
2007-02past
1
Phase 3Unnamed
Coronary Artery Disease
Completed
2009-06past
1
Phase 2Varisolve (Polidocanol Endovenous Microfoam)
Varicose Veins
Completed
2009-07past
1
Phase 3Unnamed
Atherosclerosis+1 more
Completed
2011-03past
1
Phase 3Unnamed
Biliary Stricture
Completed
2012-11past
1
Phase 3Warfarin
Atrial Fibrillation+1 more
Completed
2013-08past
2
Phase 2Unnamed
Congestive Heart Failure
Completed—1
Phase 1Unnamed
Chronic Headaches
Completed
2007-08past
1
Phase 1Polidocanol Endovenous Microfoam (PEM)
Varicose Veins
Completed
2012-01past
1
N/AUnnamed
Carotid Artery Diseases+2 more
Completed
2005-05past
1
N/AUnnamed
Long QT Syndrome+3 more
Completed
2007-12past
1
N/AUnnamed
Bradycardia+1 more
Completed
2008-02past
1
N/AUnnamed
Pain+2 more
Terminated
2008-04past
1
N/AUnnamed
Atrial Fibrillation
Terminated
2008-05-07past
1
N/AUnnamed
Back Pain+2 more
Terminated
2008-08past
1
N/AUnnamed
Uterine Fibroids+2 more
Completed
2009-02past
1
N/AUnnamed
Pain+2 more
Completed
2009-04past
1
N/AUnnamed
Tachycardia+1 more
Completed
2009-06past
1
N/AUnnamed
Heart Failure
Terminated
2009-10past
1
N/AUnnamed
Heart Diseases
Terminated
2011-01past
1
N/AUnnamed
Heart Failure
Completed
2011-03past
1
N/AUnnamed
Atrial Fibrillation
Completed
2012-09past
1
N/AUnnamed
Anastomotic Biliary Stricture Post Orthotopic Liver Transplant
Completed
2012-10past
1
N/Aprasugrel
Coronary Artery Disease
Completed
2013-03past
1
N/AUnnamed
Coronary Heart Disease
Completed
2013-03past
1
N/AUnnamed
Atherosclerosis+1 more
Completed
2013-06past
1
N/AUnnamed
Bradyarrhythmia
Completed
2013-09past
1
N/AUnnamed
Ventricular Fibrillation+1 more
Completed
2013-10past
1
N/AUnnamed
Transcatheter Aortic Valve Replacement
Completed
2014-05-30past
1
N/AUnnamed
Bradycardia+1 more
Completed
2014-10past
1
N/AUnnamed
Parkinson's Disease
Completed
2014-12past
1
N/AUnnamed
Heart Failure
Completed
2014-12past
1
N/AUnnamed
Migraine Disorders
Terminated
2015-12-01past
1
N/AUnnamed
Heart Failure
Completed
2016-04past
1
N/AUnnamed
Bradycardia
Completed
2016-06past
1
N/AUnnamed
Biliary Stricture+3 more
Completed
2016-09past
1
N/AUnnamed
Refractory Anastomotic Esophageal Strictures
Completed
2016-09-25past
1
N/AUnnamed
Aortic Stenosis
Completed
2016-10-06past
1
N/AUnnamed
Aortic Valve Stenosis
Completed
2017-04-04past
1
N/AUnnamed
Stress Urinary Incontinence
Completed
2018-01-17past
1
N/AUnnamed
Atrial Fibrillation
Completed
2018-01-23past
1
N/AUnnamed
Asthma
Completed
2019-01-10past
1
N/AUnnamed
Paroxysmal Atrial Fibrillation
Completed
2019-04-09past
1
N/AUnnamed
Emphysema
Terminated
2019-07past
1
N/AUnnamed
Pelvic Organ Prolapse
Completed
2020-02-12past
1
N/AUnnamed
Pelvic Organ Prolapse
Completed
2020-02-12past
1
N/AUnnamed
Tachycardia, Ventricular
Completed
2020-02-29past
1
N/AUnnamed
Paroxysmal Atrial Fibrillation
Completed
2020-06-23past
1
N/AUnnamed
Chronic Pain
Terminated
2020-10-01past
1
N/AUnnamed
Heart Failure+2 more
Completed
2020-12-01past
1
N/AUnnamed
Paroxysmal Atrial Fibrillation
Completed
2020-12-07past
1
N/AUnnamed
Aortic Valve Stenosis
Terminated
2020-12-09past
1
N/AUnnamed
Paroxysmal Atrial Fibrillation
Completed
2020-12-21past
1
N/AUnnamed
Benign Prostatic Hyperplasia (BPH)
Completed
2021-03-30past
1
N/AUnnamed
Aortic Valve Stenosis
Terminated
2021-03-30past
1
N/AUnnamed
Primary Prevention of Sudden Cardiac Arrest+1 more
Completed
2021-10-15past
1
N/AUnnamed
Coronary Artery Disease
Completed
2021-12-22past
1
N/AUnnamed
Arterial Occlusive Diseases+3 more
Completed
2022-03-24past
1
N/AUnnamed
Unresectable Hepatocellular Carcinoma
Completed
2022-04-30past
1
N/AUnnamed
Intraductal Papillary Mucinous Neoplasm
Active, not recruiting
2022-08-11past
1
N/AUnnamed
Chronic Pain+4 more
Completed
2022-11-22past
1
N/AUnnamed
Persistent Atrial Fibrillation
Completed
2022-12-01past
1
N/AUnnamed
Chronic Venous Disorder+2 more
Withdrawn
2022-12-31past
1
N/AUnnamed
Atherosclerosis
Completed
2023-02-22past
1
N/AUnnamed
Parkinson Disease
Completed
2023-02-27past
1
N/AUnnamed
Biliary Stones
Completed
2023-09-18past
1
N/AUnnamed
Prostate Cancer
Completed
2024-04-30past
1
N/AUnnamed
Tachycardia, Ventricular+1 more
Active, not recruiting
2024-05-06past
1
N/AUnnamed
The Focus of the Study is to Reduce the Risk of Stroke and Life-threatening Bleeding Events in Patients With Non-valvular Atrial Fibrillation
Completed
2024-05-30past
1
N/AUnnamed
Cardiovascular Diseases
Active, not recruiting
2024-08-01past
1
N/AUnnamed
Hemostasis+3 more
Completed
2024-08-07past
1
N/ASingle Antiplatelet Therapy or No Therapy (Control)
Stroke
Completed
2025-09-23past
1
N/AUnnamed
Obesity
Terminated
2026-05-26past
1
N/AUnnamed
Heart Failure
Active, not recruiting
2026-07past
1
N/AUnnamed
Respiration Rate Detection
Recruiting
2026-08
1
N/AUnnamed
Weight Regain+1 more
Recruiting
2026-11
1
N/AUnnamed
Acute Pulmonary Embolism
Recruiting
2027-03-30
1
N/AUnnamed
Malignant Biliary Stenosis
Suspended
2027-05
1
N/AUnnamed
Liver Neoplasms
Recruiting
2027-06-30
1
N/AUnnamed
Carotid Artery Stenosis
Not yet recruiting
2027-09-30
1
N/AUnnamed
Chronic Pain+5 more
Recruiting
2027-11
1
N/AUnnamed
Extracranial Carotid Artery Disease+2 more
Not yet recruiting
2028-05
1
N/AUnnamed
Motor Epilepsy
Not yet recruiting
2028-05-31
1
N/AUnnamed
Weight Loss
Recruiting
2028-06-30
1
N/AUnnamed
Atrial Fibrillation (AF)+1 more
Recruiting
2028-07
1
N/AUnnamed
Type 2 Diabetes Mellitus (T2D)+1 more
Not yet recruiting
2029-05
1
N/AUnnamed
Bradycardia+3 more
Recruiting
2029-08-31
1
N/AUnnamed
Erectile Dysfunction
Enrolling
2031-01
1
N/AUnnamed
Heart Failure+1 more
Terminated—1
N/AUnnamed
Heart Failure
Completed—1
N/AUnnamed
Asthma
Withdrawn—1
Valuation

Risk-adjusted NPV

Loading pipeline…
Peer comparison

Cohort check

No peer cohort defined for BSX. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.